Document:

Exhibit 10.14 

 

SECURITIES PURCHASE AGREEMENT

 

THIS SECURITIES
PURCHASE AGREEMENT (the “Agreement”), dated as of ·  __,
2020, by and among Assure Holdings Corp., a Nevada corporation (the “Company”), and each purchaser
identified on Exhibit A hereto (each, including its successors and assigns, a “Purchaser” and
collectively, the “Purchasers”). Capitalized terms used herein but not otherwise defined shall have the
meanings given to them in Section 1.5.

 

RECITALS

 

A.      On
the terms and subject to the conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933,
as amended (the “Securities Act”), and Rule 506(b) of Regulation D promulgated thereunder, the Company desires
to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities
of the Company as more fully described in this Agreement.

 

B.       The
Company has authorized, upon the terms and conditions stated in this Agreement, the sale and issuance (the “Offering”)
of an aggregate of 10,000,000 immediately separable Units (each, a “Unit” and, collectively, the “Units”),
with each Unit consisting of: (i) one share of Company Common Stock (the “Unit Shares”) and (ii) a Warrant (as
hereinafter defined) to acquire one share of Company Common Stock (the “Warrant Shares” and, together with the
Unit Shares, the “Shares”).

 

C.       At
the Closing, each Purchaser, severally and not jointly, wishes to purchase, and the Company wishes to sell, upon the terms and
conditions stated in this Agreement, the number of Units as hereafter specified on Exhibit A annexed hereto.

 

D.      The
Company has engaged The Benchmark Company, LLC as its placement agent (the “Placement Agent”) for the offering
of the Units on a “best efforts” basis.

 

AGREEMENT

 

NOW, THEREFORE, IN
CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

 

ARTICLE
I

PURCHASE AND SALE

 

1.1             
Authorization of Sale of Shares. The Company shall issue and sell to each Purchaser, and each Purchaser shall, severally
and not jointly, purchase from the Company, such number of Units set forth opposite their respective names on Exhibit A,
at a price per Unit equal to $0.64 (the “Price Per Unit” and the total purchase price for the Units to be paid
by each Purchaser, the “Unit Purchase Price”).

 

1.2             
Closing. Subject to the terms and conditions set forth in this Agreement, the closing of the purchase and sale of
the Units to the Purchasers by the Company (the “Closing”) will occur two business days following the satisfaction
or waiver of the conditions set forth in Sections 5.1 and 5.2, or at such other time and place or on such date as the parties may
agree upon (the “Closing Date”). The Closing shall take place at the offices of Olshan Frome Wolosky LLP, 1325
Avenue of the Americas, 15th Floor, New York, New York 10019, or at such other place as the parties may agree upon.

 

     

     

    

 

1.3             
Payment. On the Closing Date, (a) each Purchaser shall pay to the Company its Unit Purchase Price in United States
dollars and in immediately available funds, by wire transfer to the Company’s account as set forth in instructions previously
delivered to each Purchaser, (b) the Company shall irrevocably instruct the Transfer Agent to deliver to each Purchaser the number
of Unit Shares set forth opposite such Purchaser’s name on Exhibit A hereto, and (c) the Company shall issue to each
Purchaser a warrant substantially in the form attached hereto as Exhibit B (each, a “Warrant” and, collectively,
the “Warrants”) pursuant to which such Purchaser shall have the right to acquire the number of Warrant Shares
set forth opposite such Purchaser’s name on Exhibit A hereto on the terms set forth in each Warrant, and in the case
of clauses (b) and (c), duly executed on behalf of the Company and registered in the name of such Purchaser as set forth on the
Stock Registration Questionnaire included as Exhibit C hereto. The Warrants issued and sold at the Closing shall have an
initial exercise price equal to the Warrant Exercise Price.

 

1.4             
Closing Deliverables.

 

(a)              
Company. Unless other arrangements have been made with a Particular Purchaser, on or prior to the Closing Date, the
Company shall deliver or cause to be delivered to each Purchaser the following:

 

(i)             
a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited
basis, the number of Unit Shares set forth opposite such Purchaser’s name on Exhibit A hereto, registered in the name
of such Purchaser as set forth on the Stock Registration Questionnaire included as Exhibit C;

 

(ii)            
a Warrant, registered in the name of such Purchaser as set forth on the Stock Registration Questionnaire included as Exhibit
C, to purchase up to the number of shares of Company Common Stock set forth opposite such Purchaser’s name on Exhibit
A hereto (such Warrant to be delivered as promptly as practicable after the Closing Date but in no event more than five (5)
Trading Days after the Closing Date);

 

(iii)           
an opinion of counsel to the Company in form and substance reasonably satisfactory to the Purchasers; and

 

(iv)           
the Registration Rights Agreement, duly executed by the Company.

 

(b)              
Purchasers. Unless other arrangements have been made with a particular Purchaser, on or prior to the Closing Date,
each Purchaser shall deliver or cause to be delivered to the Company the following (the “Purchaser Documents”):

 

(i)             
a fully completed and duly executed Stock Registration Questionnaire in the form attached hereto as Exhibit C;

 

    2

     

    

 

(ii)            
the Registration Rights Agreement, duly executed by each Purchaser;

 

(iii)          
unless such Purchaser is a director or an executive officer (as such term is defined in Rule 501(f) of Regulation D promulgated
by the U.S. Securities and Exchange Commission (the “Commission”) under the Securities Act) of the Company as
of the Closing Date, a fully completed and duly executed Accredited Investor Qualification Questionnaire in the form attached hereto
as Exhibit E;

 

(iv)           
a fully completed and duly executed Bad Actor Questionnaire in the form attached hereto as Exhibit F; and

 

(v)            
the Unit Purchase Price by wire transfer to the account specified by the Company.

 

1.5             
Defined Terms Used in This Agreement. In addition to the terms defined elsewhere in this Agreement, the following
terms have the meanings indicated:

 

“Affiliate”
means, with respect to any Person, any other Person that directly or indirectly controls or is controlled by or under common control
with such Person. For the purposes of this definition, “control,” when used with respect to any Person, means
the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person,
whether through the ownership of voting securities, by contract or otherwise; and the terms of “affiliated,”
 “controlling” and “controlled” have meanings correlative to the foregoing.

 

“Business
Day” means any day except Saturday, Sunday and any day which shall be a legal holiday or a day on which banking institutions
in the state of New York generally are authorized or required by law or other government actions to close.

 

“Company Common
Stock” means the Company’s common stock, par value $0.001 per share.

 

“Common Stock
Equivalents” means any securities of the Company or any subsidiary which would entitle the holder thereof to acquire
at any time Company Common Stock, including without limitation, any debt, preferred stock, rights, options, warrants or other instrument
that is at any time convertible into, exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Company
Common Stock.

 

“Confidentiality
Agreements” means any confidentiality agreements previously entered into by the Company and one or more of the Purchasers.

 

“Escrow Agent”
means any bank or financial institution retained by the Company to the hold the Unit Purchase Price.

 

“Lock-Up Agreements”
means any lock-up agreements previously entered into by the Company and the entities or persons set forth on Schedule I
hereto.

 

    3

     

    

 

“OTC Markets
Group” means OTC Markets Group, Inc., the operator of OTCQB and other quotation marketplaces.

 

“OTCQB”
means the OTCQB® Venture Market operated by the OTC Markets Group.

 

“Person”
means an individual or a corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or political subdivision thereof) or other entity of any kind.

 

“Personal
Information” means any information about a person (whether an individual or otherwise) required to be disclosed to a
securities commission or other securities regulatory authority or stock exchange, whether pursuant to a form or request made by
such commission, regulatory authority or stock exchange, and includes information contained in this Agreement (including, for greater
certainty, the schedules incorporated by reference herein).

 

“Registration
Rights Agreement” means that certain Registration Rights Agreement, dated as of the Closing Date, by and between the
Company and the Purchasers, in the form of Exhibit D attached to this Agreement.

 

“Securities”
means the Units, the Warrants and the Shares.

 

“Trading Day”
means a trading day in which trading occurs on the Nasdaq Stock Market, LLC or the New York Stock Exchange, Inc., or the TSX Venture
Exchange Inc.

 

“Transaction
Documents” means this Agreement, the Warrants, the Registration Rights Agreement and the schedules and exhibits attached
hereto and thereto.

 

“Transfer
Agent” means Computershare Trust Company of Canada, the current transfer agent of the Company, with a mailing address
of 510 Burrard Street, 3rd Floor, Vancouver, B.C. V6C 3B9, Canada, and any successor transfer agent of the Company.

 

“TSXV”
means the Toronto Stock Exchange Venture Exchange.

 

“Warrant Exercise
Price” means $0.78 per Warrant Share, subject to adjustment as provided in the Warrants.

 

“$”
means United States dollars.

 

ARTICLE
II

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

1The
Company hereby represents and warrants to the Purchasers and to the Placement Agent as of the date hereof and as of the Closing
Date as follows:

 

2.1             
Organization, Good Standing and Power. The Company is a corporation duly incorporated, validly existing and in good
standing under the laws of the State of Nevada and has the requisite corporate power to own, lease and operate its properties
and assets and to conduct its business as it is now being conducted and as described in the reports filed by the Company with
the OTCQB and the TSXV pursuant to the reporting requirements of the respective trading market, the applicable securities commission
or securities regulatory authority in Canada (the “Canadian Securities Regulators”), and, to the extent applicable,
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), since January 1, 2019 through the date
hereof, including, without limitation, the Company’s most recent quarterly report for the quarterly period ended June 30,
2020, filed with the OTC Markets Group (the “OTC Quarterly Report”). Section 2.1 of the Disclosure Schedule
sets forth a list of the Company’s subsidiaries. The Company is qualified to do business as a foreign corporation and is
in good standing in every jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except for any jurisdiction(s) (alone or in the aggregate) in which the failure to be so qualified will not have a
Material Adverse Effect. For the purposes of this Agreement, “Material Adverse Effect” means any (i) effect
on the business, operations, properties, financial condition or prospects of the Company that is material and adverse to the Company
and its subsidiaries, taken as a whole, and (ii) any condition, circumstance or situation that would adversely effect the validity
of the Transaction Documents or the the ability of the Company to perform any of its obligations thereunder.

 

 

 

1 NTD: General
qualification to disclosure schedules is not acceptable. Please make specific references to specific schedules where necessary.

 

    4

     

    

 

2.2             
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and perform
the Transaction Documents, to issue and sell the Securities to be issued by the Company in accordance with the terms hereof and
to perform its obligations under the Transaction Documents. The execution, delivery and performance of this Agreement and the other
Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly
and validly authorized by all necessary corporate action, and no further consent or authorization of the Company, its board of
directors or stockholders is required therefor. When executed and delivered by the Company, this Agreement and the other Transaction
Documents shall each constitute a valid and binding obligation of the Company enforceable against the Company in accordance with
its terms, except as such enforceability may be limited by applicable bankruptcy, reorganization, moratorium, liquidation, conservatorship,
receivership or similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by
other equitable principles of general application. The Company’s board of directors has adopted resolutions authorizing and
approving the transactions contemplated by the Transaction Documents, including the issuance of the Securities to be issued by
the Company pursuant to this Agreement and the other Transaction Documents and the performance by the Company of its obligations
hereunder and thereunder.

 

2.3             
Issuance of Securities. The Unit Shares have been duly authorized and, when issued and paid for in accordance with
the terms hereof, will be validly issued, fully paid and nonassessable and free and clear of any preemptive or similar rights.
In addition, the Unit Shares will be free and clear of all liens, claims, charges, security interests or agreements, pledges, assignments,
covenants, restrictions or other encumbrances created by, or imposed by, the Company (collectively, “Encumbrances”)
and rights of refusal of any kind imposed by the Company (other than restrictions on transfer under applicable securities laws)
and the holder of the Unit Shares shall be entitled to all rights accorded to a holder of Company Common Stock. The issuance and
sale of the Warrants has been duly authorized by all necessary corporate action. The Warrant Shares have been duly authorized and,
when issued upon the due exercise of the Warrants, will be validly issued, fully paid and nonassessable and free and clear of any
preemptive or similar rights. In addition, the Warrant Shares will be free and clear of all Encumbrances and rights of refusal
of any kind imposed by the Company (other than restrictions on transfer under applicable securities laws). The Company has reserved
and will reserve, at all times that the Warrants remain outstanding, such number of shares of Company Common Stock sufficient to
enable the full exercise of the then outstanding Warrants.

 

    5

     

    

 

2.4             
No Conflicts; Governmental Approvals. The execution, delivery and performance of the Transaction Documents by the
Company, the sale and issuance of the Securities and the performance by the Company of its obligations thereunder do not and will
not (i) violate any provision of the Company’s articles of incorporation or bylaws as currently in effect, (ii) conflict
with, or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give
to others any rights of termination, amendment, acceleration or cancellation of, any agreement, mortgage, deed of trust, indenture,
note, bond, license, lease agreement, instrument or obligation to which the Company or any subsidiary is a party or by which the
Company’s or any subsidiary’s properties or assets are bound, or (iii) result in a violation of any Canadian or U.S.
federal, state or local statute, rule, regulation, order, judgment or decree (including Canadian and U.S. federal and state securities
laws and regulations) applicable to the Company or by which any property or asset of the Company or any subsidiary is bound or
affected. The Company is not required under Canadian or U.S. federal, state or local law, rule or regulation to obtain any consent,
authorization or order of, or make any filing or registration with, any court or governmental agency in order for it to execute,
deliver or perform any of its obligations under this Agreement and the other Transaction Documents or issue and sell the Securities
to be issued by the Company in accordance with the terms hereof and thereof, other than filings that have been made or consents
that have been obtained pursuant to the rules and regulations of the OTCQB or TSXV trading markets, applicable Canadian or U.S.
state or provincial securities laws and post-sale filings pursuant to applicable Canadian or U.S. federal or state securities laws
which the Company undertakes to file or obtain within the applicable time periods and the filings required to be made pursuant
to this Agreement.

 

2.5             
Capitalization. The issued and outstanding shares of capital stock of the Company have been validly issued, are fully
paid and nonassessable and are not subject to any preemptive rights, rights of first refusal or similar rights. The Company has
an authorized, issued and outstanding capitalization as set forth in the OTC Quarterly Report (other than the grant of additional
awards under the Company’s existing equity incentive plans or changes in the number of outstanding shares of Company Common
Stock due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible or exchangeable
into, shares of Company Common Stock outstanding) previously issued and outstanding. Except as disclosed in the Company’s
most recent OTC Annual Report or OTC Quarterly Report, the Company does not have outstanding any options to purchase, or any rights
or warrants to subscribe for, or any securities or obligations convertible into, or exchangeable for, or any contracts or commitments
to issue or sell, any shares of capital stock or other securities (other than the grant of additional awards under the Company’s
equity incentive plans).

 

    6

     

    

 

2.6             
Disclosure Documents, Financial Statements. Since January 1, 2019, the Company has timely filed all reports, schedules,
forms, statements and other documents required to be filed by it with the OTC Markets Group or TSXV pursuant to the reporting requirements
of the respective trading market, the Canadian Securities Regulators, and, to the extent applicable, the Exchange Act (the “Disclosure
Documents”). At the times of their respective filing, all such Disclosure Documents complied in all material respects
with the requirements of the OTCQB trading market, the TSXV trading market or the Exchange Act and the rules and regulations of
the Commission promulgated thereunder. At the times of their respective filings, such Disclosure Documents did not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under which they were made, not misleading. As of their respective dates,
the financial statements of the Company included in the Disclosure Documents complied in all material respects with applicable
accounting requirements and the published rules and regulations of the OTCQB trading market, the TSXV trading market, the Canadian
Securities Regulators, the Commission or other applicable rules and regulations with respect thereto. Such financial statements
have been prepared in accordance with generally accepted accounting principles in the United States applied on a consistent basis
during the periods involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto or (ii)
in the case of unaudited interim statements, to the extent they may not include footnotes or may be condensed or summary statements),
and fairly present in all material respects the consolidated financial position of the Company and its subsidiaries as of the dates
thereof and the results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements,
to normal recurring year-end audit adjustments).

 

2.7             
Accountants. Squar Milner LLP, as reported in the OTC Annual Report, was, at the time such report was issued, an
independent registered public accounting firm with respect to the Company and is subject to oversight by the Public Company Accounting
Oversight Board. Except as pre-approved in accordance with the requirements set forth in Section 10A of the Exchange Act and described
in the Disclosure Documents, Squar Milner LLP has not engaged in any non-audit services prohibited by subsection (g) of Section
10A of the Exchange Act on behalf of the Company or its subsidiaries.

 

2.8             
Internal Controls. The Company has established and maintains a system of internal accounting controls sufficient
to provide reasonable assurances that: (i) transactions are executed in accordance with management’s general or specific
authorization; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally
accepted accounting principles in the United States and to maintain accountability for assets; (iii) access to assets is permitted
only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is
compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences.

 

2.9             
Disclosure Controls. The Company has established and maintains disclosure controls and procedures (as such term is
defined in Rules 13a-15 and 15d-15 under the Exchange Act or by the Canadian Securities Regulators) that (A) are designed to ensure
that material information required to be disclosed by the Company in the reports it files and submits in its Disclosure Documents
is accumulated and communicated to the management of the Company, including its principal executive officer and its principal financial
officer, as appropriate, to allow timely decisions regarding required disclosure to be made; (B) provide for the periodic evaluation
of the effectiveness of such disclosure controls and procedures as of the end of the period covered by the Company’s most
recent annual or quarterly report filed with the Commission; and (C) are effective in all material respects to perform the functions
for which they were established. Since January 1, 2019, there have been no significant changes in internal controls or in other
factors with respect to the Company that could significantly affect the Company’s internal controls, including any corrective
actions with regard to significant deficiencies and material weaknesses. The Company is in compliance in all material respects
with all provisions currently in effect and applicable to the Company of the Sarbanes-Oxley Act of 2002, and all rules and regulations
promulgated thereunder or implementing the provisions thereof.

 

    7

     

    

 

2.10          
No Material Adverse Change. Except as disclosed in the Disclosure Documents, since December 31, 2019, the Company
has not (i) experienced or suffered any Material Adverse Effect, (ii) incurred any material liabilities, obligations, claims or
losses (whether liquidated or unliquidated, secured or unsecured, absolute, accrued, contingent or otherwise) other than those
incurred in the ordinary course of the Company’s business or (iii) declared, made or paid any dividend or distribution of
any kind on its capital stock.

 

2.11           No Undisclosed Events or Circumstances. Except as disclosed in the Disclosure Documents, since December
31, 2019, except for the consummation of the transactions contemplated herein, no event or circumstance has occurred or
exists with respect to the Company or its businesses, properties, prospects, operations or financial condition, which, under
applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so
publicly announced or disclosed.

 

2.12           
Litigation. Except as disclosed in the Disclosure Documents, no action, suit, proceeding or investigation is currently
pending or, to the knowledge of the Company, has been threatened in writing against the Company that: (i) concerns or questions
the validity of this Agreement; (ii) concerns or questions the right or authority of the Company to enter into the Transaction
Documents and to perform its obligations thereunder; or (iii) is reasonably likely to have a Material Adverse Effect. The Company
is neither a party to nor subject to the provisions of any material order, writ, injunction, judgment or decree of any court or
government agency or instrumentality. There is no action, suit, proceeding or investigation by the Company currently pending or
that the Company intends to initiate that would have a Material Adverse Effect.

 

2.13           
Compliance. The Company is not in violation of any provision of the Company’s articles of incorporation or
bylaws as currently in effect. Neither the Company nor any subsidiairy , (i) is in default under or in violation of (and no event
has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any
subsidiary under), nor has the Company or any subsidiary received notice of a claim that it is in default under or that it is in
violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it
or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any order
of any court, arbitrator or governmental body applicable to it or to which it or its respective properties are subject, or (iii)
is or has been in violation of any statute, rule or regulation of any governmental authority, including without limitation all
Canadian and U.S. federal, state and local laws applicable to its business, except in each case for such defaults or violations
as have not had, and could not reasonably be expected to have, a Material Adverse Effect, individually or in the aggregate.

 

    8

     

    

 

2.14           
Listing and Maintenance Requirements. Except as set forth in the Disclosure Documents, the Company is, and has no
reason to believe that it will not, upon the issuance of the Securities hereunder, continue to be, in compliance with the requirements
of the OTCQB and the TSXV trading markets for continued listing of the Company Common Stock thereon and the Company has not received
any notification that, and has no knowledge that the OTC Markets Group or the TSXV is contemplating terminating such listing. The
issuance and sale of the Securities hereunder does not contravene the rules and regulations of the OTCQB or the TSXV in any material
respect.

 

2.15           
Investment Company Act. The Company is not and, after giving effect to the offering and sale of the Securities, will
not be an “investment company” or an entity “controlled” by an “investment company,” as such
terms are defined in the Investment Company Act of 1940.

 

2.16            Private Placement. Neither the Company nor its Affiliates, nor, to the Company’s
knowledge, any Person acting on its or their behalf, (i) has engaged in any form of general solicitation or general
advertising (within the meaning of Regulation D under the Securities Act) in connection with the offer or sale of the
Securities hereunder, (ii) has, directly or indirectly, made any offers or sales of any security or solicited any offers to
buy any security, under any circumstances that would require registration of the sale and issuance by the Company of the
Securities under the Securities Act or (iii) has issued any shares of Company Common Stock or shares of any series of
preferred stock or other securities or instruments convertible into, exchangeable for or otherwise entitling the holder
thereof to acquire shares of Company Common Stock which would be integrated with the sale of the Securities to the Purchasers
for purposes of the Securities Act or of any applicable stockholder approval provisions, including, without limitation, under
the rules and regulations of any exchange or automated quotation system on which any of the securities of the Company are
listed or designated, nor will the Company or any of its Affiliates take any action or steps that would require registration
of any of the Securities under the Securities Act or cause the offering of the Securities to be integrated with other
offerings. Assuming the accuracy of the representations and warranties of the Purchasers, the offer and sale of the
Securities to be issued by the Company to the Purchasers pursuant to this Agreement will be exempt from the registration
requirements of the Securities Act. None of the Company, any of its predecessors, any director, executive officer, other
officer of the Company participating in the offering, any beneficial owner of 20% or more of the Company's outstanding voting
equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the
Securities Act but excluding the underwriters, their U.S. Affiliates, any selling group member or any person acting on any of
their behalf, as to whom the Company makes no representation, warranty or covenant) connected with the Company in any
capacity at the time of sale (each, an “Issuer Covered Person” and, together, “Issuer Covered
Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule
506(d)(1)(i)–(viii) under the Securities Act (a “Disqualification Event”). The Company has exercised
reasonable care to determine: (i) the identity of each person that is an Issuer Covered Person; and (ii) whether any Issuer
Covered Person is subject to a Disqualification Event. Neither the Company nor any of its Affiliates, nor any Person acting
on its or their behalf has, directly or indirectly, made any offers or sales of any Company security or solicited any offers
to buy any security, under circumstances that would adversely affect reliance by the Company on Section 4(a)(2) for the
exemption from registration for the transactions contemplated hereby or would require registration of the Securities under
the Securities Act.

 

    9

     

    

 

2.17           
No Manipulation of Stock. The Company has not taken and will not, in violation of applicable law, take, any action
outside the ordinary course of business designed to or that might reasonably be expected to cause or result in unlawful manipulation
of the price of the Company Common Stock.

 

2.18           
Brokers and Finders. Other than the Placement Agent, neither the Company nor any of the officers, directors or employees
of the Company has employed any broker or finder in connection with the transaction contemplated by this Agreement.

 

2.19           
OFAC. Neither the Company nor, to the Company’s knowledge, any director, officer, agent, employee, Affiliate
or person acting on behalf of the Company, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department.

 

2.20           
Shell Company Status. The Company is not, and has never been, an issuer identified in Rule 144(i)(1).

 

2.21           
Questionable Payments. Neither the Company nor any of its subsidiaries nor, to the Company’s knowledge, any
of their respective current or former stockholders, directors, officers, employees, agents or other Persons acting on behalf of
the Company or any subsidiary, has on behalf of the Company or any subsidiary or in connection with their respective businesses:
(a) used any corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political
activity; (b) made any direct or indirect unlawful payments to any governmental officials or employees from corporate funds; (c)
established or maintained any unlawful or unrecorded fund of corporate monies or other assets; (d) made any false or fictitious
entries on the books and records of the Company or any subsidiary; or (e) made any unlawful bribe, rebate, payoff, influence payment,
kickback or other unlawful payment of any nature

 

2.22           
Transactions with Affiliates. Except as disclosed in the Disclosure Documents, none of the officers or directors
of the Company and, to the Company’s knowledge, none of the employees of the Company or any subsidiary is presently a party
to any transaction with the Company or any subsidiary (other than as holders of stock options and/or warrants, and for services
as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services
to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer,
director or such employee or, to the Company’s knowledge, any entity in which any officer, director, or any such employee
has a substantial interest or is an officer, director, trustee or partner

 

2.23           
Disclosures. Neither the Company nor any Person acting on its behalf has provided the Purchasers or their agents
or counsel with any information that constitutes or might constitute material, non-public information, other than the terms of
the transactions contemplated hereby. The written materials delivered to the Purchasers in connection with the transactions contemplated
by the Transaction Documents do not contain any untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements contained therein, in light of the circumstances under which they were made, not misleading.

 

    10

     

    

 

2.24           
FDA. The Company is not subject to the rules and regulations of the U.S. Food and Drug Administration.

 

2.25           
No Fiduciary. The Company acknowledges that none of the Purchasers is acting as a financial advisor or fiduciary
of the Company (or in any similar capacity) with respect to this Agreement, the other Transaction Documents and the transactions
contemplated hereby and thereby, and any advice or other guidance provided by any Purchaser or any of its representatives and agents
with respect to this Agreement, the other Transaction Documents and the transactions contemplated hereby and thereby is merely
incidental to such Purchaser’s entry into such transactions. The Company’s decision to enter into this Agreement and
the other Transaction Documents has been based solely on the independent evaluation by the Company and its representatives and
agents.

 

2.26           
Reliance. The Company understands that the foregoing representations and warranties shall be deemed material and
to have been relied upon by the Purchasers and the Placement Agent.

 

ARTICLE
III

REPRESENTATIONS, WARRANTIES AND COVENANTS OF PURCHASERS

 

Each Purchaser, for
itself and for no other Purchaser, hereby represents, warrants and covenants to the Company and to the Placement Agent as follows:

 

3.1             
Authorization and Power. Such Purchaser has the requisite power and authority to enter into and perform the Transaction
Documents and to purchase the Securities being sold to it hereunder. The execution, delivery and performance of this Agreement
by such Purchaser and the consummation by it of the transactions contemplated hereby have been duly authorized by all necessary
corporate limited liability company or limited partnership action, and no further consent or authorization of such Purchaser or
its board of directors, stockholders or other governing body is required. When executed and delivered by such Purchaser, this Agreement
shall constitute a valid and binding obligation of such Purchaser, enforceable against such Purchaser in accordance with its terms,
except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship,
receivership or similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by
other equitable principles of general application.

 

3.2             
[Reserved]

 

    11

     

    

 

3.3             
Purchaser Sophistication; Accredited Investor. At the time such Purchaser was offered the Securities, as of the date
hereof, and on each date on which it exercises the Warrants, such Purchaser (a) is knowledgeable, sophisticated and experienced
in making, and is qualified to make decisions with respect to, investments in shares presenting an investment decision like that
involved in the purchase of the Securities, including investments in securities issued by the Company and investments in comparable
companies, and has requested, received, reviewed and considered all information it deemed relevant in making an informed decision
to purchase the Securities; (b) in connection with its decision to purchase the Securities, relied only upon the Disclosure Documents,
other publicly available information, and the representations and warranties of the Company contained herein; (c) is an “accredited
investor” pursuant to Rule 501 of Regulation D under the Securities Act; (d) is acquiring the Securities for its own account
for investment only and with no present intention of distributing any of the Securities or any arrangement or understanding with
any other persons regarding the distribution of the Securities in violation of the Securities Act notwithstanding, however, to
such Purchaser’s right at all times to sell or otherwise dispose of all or any part of such Securities in compliance with
applicable federal and state securities laws; and provided, that nothing contained herein shall be deemed a representation or warranty
by such Purchaser to hold the Securities for any period of time ; (e) has not been organized, reorganized or recapitalized specifically
for the purpose of investing in the Securities; (f) will not, directly or indirectly, offer, sell, pledge, transfer or otherwise
dispose of (or solicit any offers to buy, purchase or otherwise acquire to take a pledge of) any of the Securities except in compliance
with the Securities Act and applicable Canadian provincial and U.S. state securities laws; (g) understands that the Securities
are being offered and sold to it in reliance upon specific exemptions from the registration requirements of the Securities Act
and state securities laws, and that the Company is relying upon the truth and accuracy of, and such Purchaser’s compliance
with, the representations, warranties, agreements, acknowledgments and understandings of such Purchaser set forth herein in order
to determine the availability of such exemptions and the eligibility of such Purchaser to acquire the Securities; (h) understands
that its investment in the Securities involves a significant degree of risk, including a risk of total loss of such Purchaser’s
investment (provided that such acknowledgment in no way diminishes the representations, warranties and covenants made by the Company
hereunder); and (i) understands that no Canadian or U.S. federal or state agency or any other government or governmental agency
has passed upon or made any recommendation or endorsement of the Securities.

 

3.4            
Restricted Shares. Such Purchaser acknowledges that the Securities are restricted securities and must be held indefinitely
unless subsequently registered under the Securities Act or (if the Purchaser is not selling the Securities pursuant to Rule 144
promulgated under the Securities Act) the Company receives an opinion of counsel reasonably satisfactory to the Company that such
registration is not required. Such Purchaser is aware of the provisions of Rule 144 promulgated under the Securities Act which
provide a safe harbor for the limited resale of stock purchased in a private placement subject to the satisfaction of certain conditions
(if applicable), including, among other things, the existence of a public market for the stock, the availability of certain current
public information about the Company, the resale occurring after certain holding periods have been met, the sale being conducted
through a “broker’s transaction” or a transaction directly with a “market maker” and the number of
shares of the stock being sold during any three-month period not exceeding specified limitations. Such Purchaser further acknowledges
and understands that the Company may not be satisfying the current public information requirement of Rule 144 at the time such
Purchaser wishes to sell the Securities and, if so, such Purchaser may be precluded from selling the Securities under Rule 144
even if the required holding period has been satisfied.

 

3.5             
Residency. Such Purchaser is a resident of or an entity organized under the jurisdiction specified below its address
on Exhibit A hereto. The Purchaser is not a resident of or an entity organized under the laws of Canada or a jurisdiction
therein.

 

    12

     

    

 

3.6             
[Reserved]

 

3.7             
Stock Legends. Such Purchaser acknowledges that certificates evidencing the Securities shall bear a restrictive legend
in substantially the following form (and including related stock transfer instructions and record notations):

 

THESE SECURITIES HAVE NOT BEEN REGISTERED
WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT
(A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, (B) IN ACCORDANCE WITH RULE 144, OR (C) PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY
TO THE COMPANY.

 

3.8             
No Legal, Tax or Investment Advice. Such Purchaser understands that nothing in this Agreement or any other materials
presented by or on behalf of the Company to such Purchaser in connection with the purchase of the Securities constitutes legal,
tax or investment advice. Such Purchaser has consulted such legal, tax and investment advisors as it, in its sole discretion, has
deemed necessary or appropriate in connection with its purchase of the Securities.

 

3.9             
No General Solicitation; Pre-Existing Relationship. Such Purchaser is not purchasing the Securities as a result of
any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine, e-mail
or by electronic means on the internet, or similar media or broadcast over television or radio or presented at any seminar or any
other general solicitation or general advertisement. Such Purchaser also represents that such Purchaser was contacted regarding
the sale of the Units by the Company or the Placement Agent (or an authorized agent or representative of the Company or the Placement
Agent) with which such Purchaser had a substantial pre-existing relationship.

 

3.10            
Purchase Entirely for Own Account. The Securities to be received by such Purchaser hereunder will be acquired for
such Purchaser’s own account, not as nominee or agent, and not with a view to the resale or distribution of any part thereof
in violation of the Securities Act, and such Purchaser has no present intention of selling, granting any participation in, or
otherwise distributing the same in violation of the Securities Act without prejudice, however, to such Purchaser’s right
at all times to sell or otherwise dispose of all or any part of such Securities in compliance with applicable Canadian and U.S.
federal and state securities laws. Nothing contained herein shall be deemed a representation or warranty by such Purchaser to
hold the Securities for any period of time.

 

    
    13 

     

    

 

 

3.11          
 Experience of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge,
sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective
investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the
economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

 

3.12         
  Disclosure of Information. Such Purchaser has had an opportunity to receive all information related to the Company
requested by it and to ask questions of and receive answers from the Company and the Placement Agent regarding the Company, its
business and the terms and conditions of the offering of the Securities. Such Purchaser acknowledges receipt of copies of the Disclosure
Documents (or access thereto via the OTC Markets Group or the TSXV). Neither such inquiries nor any other due diligence investigation
conducted by such Purchaser shall modify, limit or otherwise affect such Purchaser’s right to rely on the Company’s
representations and warranties contained in this Agreement.

 

3.13            Interested Stockholders. Each Purchaser that is an “Interested Stockholder” (as such term is defined
in Section 78.423 of the Nevada Revised Statutes) represents and warrants that either (a) it has been an Interested Stockholder
for at least three years prior to the date hereof or (b) the transaction that resulted in such Purchaser becoming an Interested
Stockholder was approved by the Company’s board of directors or a duly authorized committee thereof.

 

3.14          
No Rule 506 Disqualifying Activities. Such Purchaser has not taken any of the actions set forth in, and is not subject
to, the disqualification provisions of Rule 506(d)(1) under the Securities Act.

 

3.15           
Brokers and Finders. No Person will have, as a result of the transactions contemplated by this Agreement, any valid
right, interest or claim against or upon the Company or such Purchaser for any commission, fee or other compensation pursuant to
any agreement, arrangement or understanding entered into by or on behalf of such Purchaser.

 

3.16           
Regulation M. Such Purchaser is aware that the anti-manipulation rules of Regulation M under the Exchange Act may
apply to sales of Company Common Stock and other activities with respect to Company Common Stock.

 

3.17           
Canadian Distribution. The Purchaser acknowledges that the Securities have not been qualified for distribution by
a prospectus in Canada and may not be offered or sold in Canada during the course of the distribution except pursuant to a prospectus
filed with a securities commission in Canada or pursuant to an exemption from the prospectus requirements.

 

3.18           
Personal Information. The Purchaser acknowledges that this Agreement requires the Purchaser to provide certain Personal
Information to the Company and its agents and advisers as reasonably necessary in connection with the Offering. Such information
is being collected and will be used by the Company for the purposes of completing the Offering of the Securities, which includes,
without limitation, determining the Purchaser’s eligibility to purchase the Securities under applicable Canadian and U.S.
securities laws and completing filings required by the applicable securities commission or other securities regulatory authority.
The Purchaser agrees that the Purchaser’s Personal Information may be disclosed by the Company to: (i) stock exchanges and
applicable securities regulatory authorities, including the applicable securities commission; (ii) the Company’s Transfer
Agent; (iii) the applicable taxing authorities; and (iv) any of the other parties involved in the proposed Offering, including
legal counsel, and may be included in record books in connection with the Offering. By executing and delivering this Agreement,
the Purchaser consents to the foregoing collection, use, and disclosure of the Purchaser’s Personal Information. The Purchaser
also consents to the filing of copies or originals of any of the Purchaser Documents described in Section 1.4(b) hereof as may
be required to be filed with any stock exchange or securities commission in connection with the transactions contemplated hereby.

 

    14 

     

    

 

3.19           
Prohibited Transactions. Since the earlier of (a) such time as such Purchaser was first contacted by the Company or any
other Person acting on behalf of the Company regarding the transactions contemplated hereby or (b) thirty (30) days prior to the
date hereof, neither such Purchaser nor any Affiliate of such Purchaser which (x) had knowledge of the transactions contemplated
hereby, (y) has or shares discretion relating to such Purchaser’s investments or trading or information concerning such Purchaser’s
investments, including in respect of the Securities, or (z) is subject to such Purchaser’s review or input concerning such
Affiliate’s investments or trading (collectively, “Trading Affiliates”) has, directly or indirectly, effected
or agreed to effect any short sale, whether or not against the box, established any “put equivalent position” (as defined
in Rule 16a-1(h) under the Exchange Act) with respect to the Company Common Stock, granted any other right (including, without
limitation, any put or call option) with respect to the Company Common Stock or with respect to any security that includes, relates
to or derived any significant part of its value from the Common Stock or otherwise sought to hedge its position in the Securities
(each, a “Prohibited Transaction”). Prior to the earliest to occur of (i) the termination of this Agreement,
(ii) the Effective Date or (iii) the Effectiveness Deadline (as such terms are defined in the Registration Rights Agreement), such
Purchaser shall not, and shall cause its Trading Affiliates not to, engage, directly or indirectly, in a Prohibited Transaction.
Such Purchaser acknowledges that the representations, warranties and covenants contained in this Section 3.19 are being made for
the benefit of the Purchasers as well as the Company and that each of the other Purchasers shall have an independent right to assert
any claims against such Purchaser arising out of any breach or violation of the provisions of this Section 3.19.

 

ARTICLE
IV

COVENANTS OF THE PARTIES

 

4.1             
Agreement to Lock-Up. The Company shall cause its officers and directors and holders of 5% or more of the outstanding
shares of Company Common Stock to enter into Lock-Up Agreements with the Company and the Placement Agent pursuant to which they
will agree that they will not, without the prior written consent of the Company and the Placement Agent, during the period commencing
on the Closing Date and ending on the date that is sixty (60) days after the date of the Company’s final prospectus is first
filed pursuant to Rule 424(b)(3) under the Securities Act with respect to the registration with the Commission of the Shares for
resale, offer, sell, contract to sell, pledge, grant any option to purchase or otherwise dispose of any Securities, or any securities
convertible into or exercisable or exchangeable for, or any rights to purchase or otherwise acquire, any Company Common Stock held
by such person or entity or acquired by such person or entity after the date hereof, or that may be deemed to be beneficially owned
by such person or entity; provided, that (a) this Section 4.1 shall not apply to any transfer of Securities by a Purchaser
to its Affiliates, provided that as a condition of such transfer, such Affiliate agrees in writing to be bound by the provisions
of this Section 4.1 to the same extent as such Purchaser; (b) this Section 4.1 shall not apply to any shares of Company Common
Stock being offered in the prospectus included in the registration statement covering the resale of the Shares in accordance with
the Registration Rights Agreement; and (c) this Section 4.1 shall not apply to the sale of up to $600,000 worth of Company Common
Stock by Preston Parsons, the founder of the Company, to enable him to satisfy outstanding tax obligations.

 

    15 

     

    

 

4.2             
Further Transfers. Each Purchaser covenants that the Securities will only be sold, offered for sale, pledged, loaned,
or otherwise disposed of pursuant to an effective registration statement under, and in compliance with the requirements of, the
Securities Act or pursuant to an available exemption from the registration requirements of the Securities Act, and in compliance
with any applicable state securities laws. In connection with any transfer of Securities other than pursuant to an effective registration
statement or Rule 144, the Company may require such Purchaser to provide to the Company an opinion of counsel selected by such
Purchaser, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration under the Securities Act.

 

4.3             
No Integration. The Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate
of the Company shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined
in Section 2 of the Securities Act) that will be integrated with the offer or sale of the Securities pursuant to this Agreement
in a manner that would require the registration under the Securities Act of the sale of the Securities to the Purchasers, or that
will be integrated with the offer or sale of the Securities pursuant to this Agreement for purposes of the rules and regulations
of the OTC Markets Group or the TSXV such that it would require stockholder approval prior to the closing of such other transaction
unless stockholder approval is obtained before the closing of such subsequent transaction. The Purchasers shall take no action
to become a group such that any transactions contemplated by this Agreement would require shareholder approval prior to Closing.

 

4.4             
Removal of Legends. In connection with any sale or disposition of the Securities by a Purchaser pursuant to Rule
144 or pursuant to any other exemption under the Securities Act such that the Purchaser acquires freely tradable shares and upon
compliance by the Purchaser with the requirements of this Agreement, the Company shall or, in the case of Company Common Stock,
shall cause the Transfer Agent for the Company Common Stock to issue replacement certificates representing the Securities sold
or disposed of without restrictive legends. Upon the earlier of (i) registration for resale pursuant to the Registration Rights
Agreement or (ii) the Unit Shares becoming freely tradable by a non-affiliate pursuant to Rule 144 the Company shall (A) deliver
to the Transfer Agent irrevocable instructions that the Transfer Agent shall reissue a certificate representing Unit Shares without
legends upon receipt by such Transfer Agent of the legended certificates for such shares, together with either (1) a customary
representation by the Purchaser that Rule 144 applies to the shares of Common Stock represented thereby or (2) a statement by the
Purchaser that such Purchaser will sell (or, in the case of any Affiliate of the Company has sold) has sold the shares of Company
Common Stock represented thereby in accordance with the Plan of Distribution contained in the Registration Statement, and (B) cause
its counsel to deliver to the Transfer Agent one or more blanket opinions to the effect that the removal of such legends in such
circumstances may be effected under the Securities Act. From and after the earlier of such dates, upon an Purchaser’s written
request, the Company shall promptly cause certificates evidencing the Purchaser’s Securities to be replaced with certificates
which do not bear such restrictive legends, and Warrant Shares subsequently issued upon due exercise of the Warrants shall not
bear such restrictive legends provided the provisions of either clause (i) or clause (ii) above, as applicable, are satisfied with
respect to such Warrant Shares. When the Company is required to cause an unlegended certificate to replace a previously issued
legended certificate, if: (1) the unlegended certificate is not delivered to a Purchaser within three (3) Trading Days of submission
by that Purchaser of a legended certificate and supporting documentation to the Transfer Agent as provided above and (2) prior
to the time such unlegended certificate is received by the Purchaser, the Purchaser, or any third party on behalf of such Purchaser
or for the Purchaser’s account, purchases (in an open market transaction or otherwise) shares of Company Common Stock to
deliver in satisfaction of a sale by the Purchaser of shares represented by such certificate (a “Buy-In”), then
the Company shall pay in cash to the Purchaser (for costs incurred either directly by such Purchaser or on behalf of a third party)
the amount by which the total purchase price paid for Company Common Stock as a result of the Buy-In (including brokerage commissions,
if any) exceeds the proceeds received by such Purchaser as a result of the sale to which such Buy-In relates. The Purchaser shall
provide the Company written notice indicating the amounts payable to the Purchaser in respect of the Buy-In.

 

    16 

     

    

 

4.5             
Subsequent Equity Sales; Registration Statements.

 

   (a)       From
the date hereof until ninety (90) days after the Closing Date, without the consent of the Required Purchasers, neither the Company
nor any subsidiary shall issue shares of Company Common Stock or Common Stock Equivalents. Notwithstanding the foregoing, the provisions
of this Section 4.5(a) shall not apply to (i) the issuance of the Securities, (ii) the issuance of Company Common Stock or Common
Stock Equivalents upon the conversion or exercise of any securities of the Company or a subsidiary outstanding on the date hereof,
provided that the terms of such security are not amended after the date hereof to decrease the exercise price or increase the Company
Common Stock or Common Stock Equivalents receivable upon the exercise, conversion or exchange thereof or (iii) the issuance of
any Company Common Stock or Common Stock Equivalents pursuant to any Company equity incentive plan approved by the Company’s
stockholders and in place as of the date hereof or proposed for approval at the Company’s 2020 annual meeting of shareholders.

 

   (b)       From
the date hereof until the earlier of (i) two years after the Closing Date or (ii) such time as Purchasers, collectively, beneficially
own less than five percent (5%) of the Company Common Stock, the Company shall be prohibited from effecting or entering into an
agreement to effect any “Variable Rate Transaction”. The term “Variable Rate Transaction”
shall mean a transaction in which the Company issues or sells (i) any debt or equity securities that are convertible into, exchangeable
or exercisable for, or include the right to receive additional shares of Company Common Stock either (A) at a conversion, exercise
or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the shares of Company
Common Stock at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange
price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the
occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the
Company Common Stock or (ii) enters into any agreement, including, but not limited to, an equity line of credit, whereby the Company
may sell securities at a future determined price. For the avoidance of doubt, the issuance of a security which is subject to customary
anti-dilution protections, including where the conversion, exercise or exchange price is subject to adjustment as a result of stock
splits, reverse stock splits and other similar recapitalization or reclassification events, shall not be deemed to be a “Variable
Rate Transaction”.

 

    17 

     

    

 

   (c)       The
Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the Company shall, sell, offer
for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities
Act) that will be integrated with the offer or sale of the Securities in a manner that would require the registration under the
Securities Act of the sale of the Securities to the Purchasers, or that will be integrated with the offer or sale of the Securities
for purposes of the rules and regulations of any trading market such that it would require stockholder approval prior to the closing
of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.

 

   (d)       The
Company shall not, from the date hereof until ninety (90) days after the Effective Date, prepare and file with the SEC a registration
statement relating to an offering for its own account or the account of others under the Securities Act of any of its equity securities,
other than (i) a Registration Statement pursuant to the Registration Rights Agreement, (ii) any registration statement or post-effective
amendment to a registration statement (or supplement thereto) relating to the Company’s employee benefit plans registered
on Form S-8 or, in connection with an acquisition, on Form S-4, or (iii) a registration statement covering a firm commitment
underwritten public offering by the Company of its shares of Company Common Stock that will result in the listing of such shares
for trading on the Nasdaq Stock Market or the New York Stock Exchange.

 

4.6             
Equal Treatment of Purchasers. No consideration shall be offered or paid to any Person to amend or consent to a waiver or
modification of any provision of any of the Transaction Documents unless the same consideration is also offered to all of the parties
to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each Purchaser
by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class
and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.

 

    18 

     

    

 

ARTICLE
V

CONDITIONS TO CLOSING

 

5.1              Conditions
Precedent to the Obligations of the Purchasers. The obligation of the Purchasers to acquire the Securities at the Closing
is subject to the satisfaction or waiver by the Purchasers, at or before the Closing, of each of the following conditions:

 

   (a)       Representations and Warranties. The representations and warranties of the Company contained in Article II shall be
true and correct in all respects as of the date of this Agreement and as of the Closing Date, except to the extent any such representation
or warranty expressly speaks as of an earlier date, in which case such representation or warranty shall be true and correct as
of such earlier date, and, the representations and warranties made by the Company in Article II hereof not qualified as to materiality
shall be true and correct in all material respects as of the date hereof and the Closing Date, except to the extent any such representation
or warranty expressly speaks as of an earlier date, in which case such representation or warranty shall be true and correct in
all material respects as of such earlier date.

 

   (b)       Performance.
The Company shall have performed and complied, in all material respects, with all covenants, agreements, obligations and conditions
contained in this Agreement that are required to be performed or complied with by the Company on or before the Closing, including,
without limitation, the delivery by the Company of the items contemplated by Section 1.4(a).

 

   (c)       No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any
of the transactions contemplated by the Transaction Documents.

 

   (d)       No OTCQB or TSXV Objection. The OTC Markets Group or the TSXV shall have raised no objection to the consummation
of the transactions contemplated by the Transaction Documents in the absence of stockholder approval of such transactions.

 

   (e)       Registration Rights Agreement. The Company shall have executed and delivered the Registration Rights Agreement, and
the Registration Rights Agreement shall be in full force and effect.

 

   (f)        Lock-Up
Agreements. The Placement Agent shall have received copies of the Lock-up Agreements executed by each entity or person listed
on Schedule I.

 

   (g)       Approval
of TSXV. The TSXV shall have conditionally approved the issuance of the Securities.

 

5.2             
Conditions Precedent to the Obligations of the Company. The obligation of the Company to issue the Securities at
the Closing is subject to the satisfaction or waiver by the Company, at or before the Closing, of each of the following conditions:

 

   (a)       Representations
and Warranties. The representations and warranties of each Purchaser contained in Article III shall be true and correct in
all respects as of the Closing (unless as of a specific date therein in which case they shall be accurate as of such date).

 

   (b)       Performance.
Each Purchaser shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions
required by the Transaction Documents to be performed, satisfied or complied with by such Purchaser at or prior to the Closing,
including, without limitation, the delivery by each Purchaser of the items contemplated by Section 1.4(b).

 

    19 

     

    

 

   (c)       No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation
of any of the transactions contemplated by the Transaction Documents.

 

   (d)       No
OTCQB or TSXV Objection. The OTC Markets Group or the TSXV shall have raised no objection to the consummation of the transactions
contemplated by the Transaction Documents in the absence of stockholder approval of such transactions.

 

   (e)       Registration
Rights Agreement. Each Purchaser shall have executed and delivered the Registration Rights Agreement, and the Registration
Rights Agreement shall be in full force and effect.

 

   (f)        Lock-Up
Agreements. The Placement Agent shall have received copies of the Lock-up Agreements executed by each entity or person listed
on Schedule I.

 

   (g)       Approval
of TSXV. The TSXV shall have conditionally approved the issuance of the Securities.

 

ARTICLE
VI

TERMINATION

 

6.1              Termination.
In addition to the provisions of Section 7.6, in the event that the Closing shall not have occurred with respect to a Purchaser
on or before ten (10) Business Days from the date hereof due to the Company’s or such Purchaser’s failure to satisfy
the conditions set forth in Section 5 above (and the nonbreaching party’s failure to waive such unsatisfied condition(s)),
the nonbreaching party shall have the option to terminate this Agreement with respect to such breaching party at the close of
business on such date without liability of any party to any other party.

 

ARTICLE
VII

MISCELLANEOUS

 

7.1              Survival
of Warranties. Unless otherwise set forth in this Agreement, the representations and warranties of the Company and the Purchasers
contained in or made pursuant to this Agreement shall survive the Closing and the delivery of the Securities.

 

7.2              No
Finder’s Fees. The Company agrees to indemnify and to hold harmless the Purchasers from any liability for any commission
or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses
of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives
is responsible

 

7.3             
Fees and Expenses. Each party shall pay the fees and expenses of its advisors, counsel, accountants and other experts,
if any, and all other expenses, incurred by such party incident to the negotiation, preparation, execution, delivery and performance
of this Agreement.

 

    20 

     

    

 

7.4             
Entire Agreement. The Transaction Documents, together with the Exhibits and Schedules thereto, contain the entire
understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral
or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules;
provided, however, that any Confidentiality Agreements previously entered into between the Company and any Purchasers
shall remain in full force and effect. At or after the Closing, and without further consideration, the Company will execute and
deliver to the Purchasers, and the Purchasers will execute and deliver to the Company, such further documents as may be reasonably
requested in order to give practical effect to the intention of the parties under the Transaction Documents.

 

7.5             
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder
shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or
communication is delivered via facsimile or email at the facsimile number or email address specified in this Section 7.5 prior
to 4:00 p.m. (Eastern time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication
is delivered via facsimile or email at the facsimile number or email address specified in this Section on a day that is not a Trading
Day or later than 4:00 p.m. (Eastern time) on any Trading Day, (c) the Trading Day following the date of deposit with a nationally
recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The
addresses, facsimile numbers and email addresses for such notices and communications are those set forth below, or such other address
or facsimile number as may be designated in writing hereafter, in the same manner, by any such Person:

 

	If to the Company:	
        Assure Holdings Corp.

        4600 South Ulster Street, Suite 1225

        Denver, CO 80237

        Attention: John Allen Farlinger, Chairman & CEO

        Email: john.farlinger@assureiom.com

        Fax No.:

	 	 
	with copies (which copies

shall not constitute notice

to the Company) to:	
        Dorsey & Whitney LLP

        1400 Wewatta Street, Suite 400

        Denver, CO 80202

        Attention: Kenneth G. Sam, Esq.

        Email: sam.kenneth@dorsey.com

        Fax No.: (416) 367-7371

	 	 
	If to the Purchasers:	To their respective addresses as set forth on Exhibit A attached hereto.

 

7.6             
Amendments; Waivers. This Agreement and any term hereof may be amended, terminated or waived only with the written
consent of the Company and (i) with respect to an amendment, termination or waiver prior to the Closing, (X) each Purchaser which,
together with its Affiliates, has agreed to purchase at least 25% of the Units to be issued at the Closing and (Y) the Purchasers
obligated to purchase a majority of the Units to be issued at the Closing, and (ii) with respect to an amendment, termination or
waiver after the Closing, (X) each Purchaser who, together with its Affiliates, beneficially owns at least 9.99% of the Shares
and (Y) the Purchasers beneficially owning at least a majority of the Unit Shares then beneficially owned by all Purchasers (collectively
in each of clauses (i) and (ii), the “Required Purchasers”) . No waiver of any default with respect to any provision,
condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent
default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of either party to
exercise any right hereunder in any manner impair the exercise of any such right.

 

    21 

     

    

 

7.7             
Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall
not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party.

 

7.8             
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written
consent of each Purchaser; provided, however, that no such consent shall be required in connection with any assignment
(i) occurring by operation of law in connection with any merger or consolidation to which the Company is a party, (ii) in connection
with the acquisition of all or substantially all of the assets of the Company or (iii) any other similar business combination transaction
involving the Company. A Purchaser may assign its rights under this Agreement in connection with the sale or transfer of some or
all of its Securities provided, that (i) as a condition of such sale or transfer, such transferee agrees in writing to be
bound by all of the terms and conditions of this Agreement as a party hereto and (ii) such sale or transfer shall have been made
in accordance with the applicable securities laws.

 

7.9              Persons
Entitled to Benefit of Agreement. Except for the Placement Agent, this Agreement is intended for the benefit of the parties
hereto and their respective permitted successors and assigns and is not for the benefit of, nor may any provision hereof be enforced
by, any other person.

 

7.10           
Governing Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the internal
laws of the State of New York without regard to the conflict of law principles thereof. Each of the parties hereto irrevocably
submits to the exclusive jurisdiction of the state and federal courts located in the State of New York for the purpose of any suit,
action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated hereby. Service of
process in connection with any such suit, action or proceeding may be served on each party hereto anywhere in the world by the
same methods as are specified for the giving of notices under this Agreement. Each of the parties hereto irrevocably consents to
the jurisdiction of any such court in any such suit, action or proceeding and to the laying of venue in such court. Each party
hereto irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts and
irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient
forum. If any party hereto shall commence an action or proceeding to enforce any provisions of the Transaction Documents, then,
the prevailing party in such action or proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys’
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

    22 

     

    

 

7.11           
Counterparts; Execution. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile,
electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com)
or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid
and effective for all purposes.

 

7.12            Severability.
If any provision hereof should be held invalid, illegal or unenforceable in any respect, then, to the fullest extent permitted
by law, (a) all other provisions hereof shall remain in full force and effect and shall be liberally construed in order to carry
out the intentions of the parties as nearly as may be possible, and (b) the parties shall use their best efforts to replace the
invalid, illegal or unenforceable provision(s) with valid, legal and enforceable provision(s) which, insofar as practical, implement
the purposes of such provision(s) in this Agreement.

 

7.13         
  Adjustments in Share Numbers and Prices. In the event of any stock split, subdivision, dividend or distribution payable
in shares of Company Common Stock (or other securities or rights convertible into, or entitling the holder thereof to receive directly
or indirectly shares of Company Common Stock), combination or other similar recapitalization or event occurring after the date
hereof, each reference in any Transaction Document to a number of shares or a price per share shall be deemed to be amended to
appropriately account for such event.

 

[Signature pages to follow]

 

    23 

     

    

 

 

IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective
authorized signatories as of the date first indicated above.

 

	 	THE COMPANY:

 

	 	ASSURE HOLDINGS CORP.
	 	 
	 	 
	 	By:	 
	 	 	Name:	John Allen Farlinger
	 	 	Title:	Chairman and Chief Executive Officer

 

     

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective
authorized signatories as of the date first indicated above.

 

	 	PURCHASERS:
	 	 
	 	[PURCHASER]
	 	 
	 	 
	 	By:	      
	 	 	Name:
	 	 	Title:
	 	 
	 	Address for Notice:
	 	 
	 	
	 	 
	 	
	 	 
	 	

 

	 	Telephone No.:	 
	 	 
	 	Facsimile No.:	 
	 	 
	 	E-mail Address:	 
	 	 
	 	Attention:Exhibit 10.15

 

REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION RIGHTS
AGREEMENT (this “Agreement”) is made and entered into as of · __, 2020, by and among Assure Holdings
Corp., a Nevada corporation (the “Company”), and the purchasers set forth on Schedule 1 hereto (each,
a “Purchaser” and, collectively, the “Purchasers”), and shall become effective as of the
Closing (as defined in the Purchase Agreement, defined below).

 

RECITALS

 

A.               
In connection with the Securities Purchase Agreement, by and among the Company and the Purchasers, dated as of · __, 2020 (the “Purchase Agreement”), the Company has agreed, upon the terms and conditions stated in the Purchase
Agreement, to issue and sell to each Purchaser on the Closing Date immediately separable Units, with each Unit consisting of: (i)
one share of Common Stock (the “Unit Shares”) and (ii) a Warrant to acquire one share of Common Stock (the “Warrant
Shares” and, together with the Unit Shares, the “Shares”).

 

B.                
To induce the Purchasers to execute and deliver the Purchase Agreement, the Company has agreed to provide certain registration
rights under the Securities Act, and applicable state securities laws.

 

AGREEMENT

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration
the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

 

ARTICLE
I

DEFINITIONS

 

Capitalized terms used
and not otherwise defined herein shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement,
the following terms shall have the following meanings:

 

“Affiliate”
means, with respect to any Person, any other Person that directly or indirectly controls or is controlled by or under common control
with such Person. For the purposes of this definition, “control,” when used with respect to any Person, means
the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person,
whether through the ownership of voting securities, by contract or otherwise; and the terms “affiliated,” “controlling”
and “controlled” have meanings correlative to the foregoing.

 

“Board”
means the Board of Directors of the Company.

 

“Business
Day” means any day except Saturday, Sunday and any day which shall be a legal holiday or a day on which banking institutions
in the state of New York generally are authorized or required by law or other government actions to close.

 

     

     

    

 

“Closing Date”
means the date of the closing of the acquisition and issuance of the Company Shares pursuant to the Purchase Agreement.

 

“Commission”
means the U.S. Securities and Exchange Commission.

 

“Effectiveness
Date” means the date the Registration Statement has been declared effective by the Commission.

 

“Effectiveness
Deadline” means the date which is the earlier of (x) (i) in the event that the Registration Statement is not subject
to a full review by the Commission, ninety (90) calendar days after the Closing Date or the Qualification Date, as applicable,
or (ii) in the event that the Registration Statement is subject to a full review by the Commission, one hundred twenty (120) calendar
days after the Closing Date or the Qualification Date, as applicable, and (y) the fifth (5th) Business Day after the date the Company
is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be reviewed
or will not be subject to further review; provided, however, that (i) if the Effectiveness Deadline falls on a Saturday,
Sunday or other day that the Commission is closed for business, the Effectiveness Deadline shall be extended to the next Business
Day on which the Commission is open for business, and (ii) the Effectiveness Deadline shall be extended for an additional sixty
(60) calendar days if the Registration Statement is not declared effective by the SEC on or before February 11, 2021 and in such
event the liquidated damages penalty for failure to have the Registration Statement declared effective by the Effectiveness Deadline
will not commence until the end of such sixty (60) day period.

 

“Effectiveness
Failure” shall have the meaning set forth in Section 2.2.

 

“Effectiveness
Period” shall have the meaning set forth in Section 2.1(a).

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

“Failure”
or “Failures” shall have the meaning set forth in Section 2.2.

 

“Filing Date”
or “Filing Deadline” means the thirtieth (30th) calendar day following the Closing Date; provided, however,
that if the Filing Date falls on a day that is not a Business Day, then the Filing Date shall be extended to the next Business
Day.

 

“Filing Failure”
shall have the meaning set forth in Section 2.2.

 

“Holder”
or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

 

“Indemnified
Party” shall have the meaning set forth in Section 5.3(a).

 

“Indemnifying
Party” shall have the meaning set forth in Section 5.3(a).

 

“Losses”
shall have the meaning set forth in Section 5.1.

 

    2

     

    

 

“Person”
means an individual or a corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or political subdivision thereof) or other entity of any kind.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding,
such as a deposition), whether commenced or threatened.

 

“Prospectus”
means any prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated
under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of
any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to any
such Prospectus, including post-effective amendments, and all material incorporated by reference in such Prospectus.

 

“Registrable
Securities” means (i) the Unit Shares issued to the Purchasers and (ii) the Warrant Shares issued or issuable to the
Purchasers upon exercise of the Warrants; provided, however, that the applicable Holder has completed and delivered
to the Company a Selling Stockholder Questionnaire; and provided further that such securities shall no longer be deemed Registrable
Securities if (i) such securities have been sold pursuant to a Registration Statement, (ii) such securities have been sold in compliance
with Rule 144, or (ii) such securities become eligible for resale without volume or manner-of-sale restrictions and without current
public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered and acceptable
to the Transfer Agent and the affected holders (assuming that such securities and any securities issuable upon exercise, conversion
or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any Affiliate
of the Company, and all Warrants are exercised by “cashless exercise” as provided in the Warrants), as reasonably determined
by the Company, upon the advice of counsel to the Company and the Transfer Agent has issued certificates for such Registrable Securities
to the holder thereof, or as such holder may direct, without any restrictive legend.

 

“Registration
Delay Payments” shall have the meaning set forth in Section 2.2.

 

“Registration
Statement” means the registration statements and any additional registration statements contemplated by Article II, including
(in each case) the related Prospectus, amendments and supplements to such registration statement or Prospectus, including pre-
and post-effective amendments, all exhibits thereto, and all material incorporated by reference in such registration statement.

 

“Rule 144”
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or
any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

    3

     

    

 

“Rule 415”
means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or
any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Securities
Act” means the Securities Act of 1933, as amended.

 

“Selling Stockholder
Questionnaire” means a questionnaire in the form attached as Annex B hereto, or such other form of questionnaire
as may reasonably be requested by the Company from time to time.

 

“Transaction
Documents” means this Agreement, the Purchase Agreement, the Warrants and the schedules and exhibits attached hereto
and thereto.

 

“Unit Purchase
Price” means the total purchase price for the Shares to be paid by each Purchaser pursuant to the Purchase Agreement.

 

ARTICLE
II

REGISTRATION

 

2.1             
Registration Obligations; Filing Date Registration.

 

(a)              
As promptly as practicable following the Closing Date, the Company shall use reasonable best efforts to prepare and file
with the Commission a Registration Statement covering the resale of the
Registrable Securities as would permit the sale and distribution of all the Registrable Securities from time to time pursuant
to Rule 415 in the manner reasonably requested by the Holder. The Registration Statement shall be on Form S-1. The Registration
Statement shall contain the “Plan of Distribution” section in substantially the form attached hereto as Annex A, subject
to any Commission comments; provided, however, that no Purchaser shall be named as an “underwriter” in
the Registration Statement without the Purchaser’s prior written consent. Such Registration Statement also shall cover, to
the extent allowable under the Securities Act and the rules promulgated thereunder (including Rule 416), such indeterminate number
of additional shares of Company Common Stock resulting from stock splits, stock dividends or similar transactions with respect
to the Registrable Securities. Such Registration Statement shall not include any shares of Company Common Stock or other securities
for the account of any other holder without the prior written consent of the Required Holders (as defined in Section 7.3 hereof).
The Company shall use reasonable best efforts to cause the Registration Statement filed by it to be declared effective under the
Securities Act as promptly as practicable after the filing thereof but in any event prior to the Effectiveness Deadline, and, subject
to Section 3.1(m) hereof, to keep such Registration Statement continuously effective under the Securities Act until such date as
all Registrable Securities covered by such Registration Statement have ceased to be Registrable Securities (the “Effectiveness
Period”). By 4:00 p.m., Eastern time, on the Business Day following the Effective Date, the Company shall file with the
Commission in accordance with Rule 424(b)(3) under the Securities Act the final prospectus to be used in connection with sales
pursuant to such Registration Statement.

 

(b)              
Promptly following the date (the “Qualification Date”) upon which the Company becomes eligible to use
a registration statement on Form S-3 to register the Registrable Securities for resale, but in no event more than thirty (30) days
after the Qualification Date (the “Qualification Deadline”), the Company shall file a registration statement
on Form S-3 covering the Registrable Securities (or a post-effective amendment on Form S-3 to the registration statement on Form
S-1) (a “Shelf Registration Statement”) and shall use commercially reasonable efforts to cause such Shelf Registration
Statement to be declared effective as promptly as practicable thereafter.

 

    4

     

    

 

(c)              
If at any time the Commission takes the position that the offering of some or all of the Registrable Securities in the Registration
Statement is not eligible to be made on a delayed or continuous basis under the provisions of Rule 415 under the Securities Act
or requires any Purchaser to be named as an “underwriter”, the Company shall use its best efforts to persuade the Commission
that the offering contemplated by the Registration Statement is a bona fide secondary offering and not an offering “by or
on behalf of the issuer” as defined in Rule 415 and that none of the Purchasers is an “underwriter”. The Purchasers
shall have the right to participate or have their counsel participate in any meetings or discussions with the Commission regarding
the Commission’s position and to comment or have their counsel comment on any written submission made to the Commission with
respect thereto. No such written submission shall be made to the Commission to which the Purchasers’ counsel reasonably objects.
In the event that, despite the Company’s best efforts and compliance with the terms of this Section 2.1(c), the Commission
refuses to alter its position, the Company shall (i) remove from the Registration Statement such portion of the Registrable Securities
(the “Cut Back Shares”) and/or (ii) agree to such restrictions and limitations on the registration and resale
of the Registrable Securities as the Commission may require to assure the Company’s compliance with the requirements of Rule
415 (collectively, the “SEC Restrictions”); provided, however, that the Company shall not agree to name any
Purchaser as an “underwriter” in such Registration Statement without the prior written consent of such Purchaser. Any
cut-back imposed on the Purchasers pursuant to this Section 2.1(c) shall be allocated among the Purchasers on a pro rata basis
and shall be applied first to any Warrant Shares, unless the SEC Restrictions otherwise require or provide or the Purchasers otherwise
agree. No liquidated damages shall accrue as to any Cut Back Shares until such date as the Company is able to effect the registration
of such Cut Back Shares in accordance with any SEC Restrictions (such date, the “Restriction Termination Date”
of such Cut Back Shares). From and after the Restriction Termination Date applicable to any Cut Back Shares, all of the provisions
of this Section 2 (including the liquidated damages provisions) shall again be applicable to such Cut Back Shares; provided, however,
that (i) the Filing Deadline and the Qualification Deadline for the Registration Statement including such Cut Back Shares shall
be ten (10) Business Days after such Restriction Termination Date, and (ii) the Effectiveness Deadline shall be the 60th day immediately
after the Restriction Termination Date. The Company will file such additional Registration Statements at the earliest practicable
date on which the Company is permitted by SEC Restrictions to file such additional Registration Statements related to the Registrable
Securities, each registering the Rule 415 Amount, seriatim, until all of the Registrable Securities have been registered.

 

2.2             
Effect of Failure to File Registration Statement. If (i)(X) a Registration Statement covering all of the Registrable
Securities required to be covered thereby and required to be filed by the Company pursuant to this Agreement is not filed with
the Commission by the Filing Deadline or (Y) a Shelf Registration Statement is not filed with the Commission by the Qualification
Deadline (a “Filing Failure”), (ii) such Registration Statement or the Shelf Registration Statement, as applicable,
is not declared effective by the Commission on or before the Effectiveness Deadline (an “Effectiveness Failure”),
or (iii) after a Registration Statement has been declared effective by the Commission, such Registration Statement is not available
for sales of the Registrable Securities for any reason (including without limitation by reason of a stop order, or the Company’s
failure to update the Registration Statement), but excluding any Allowed Delay (as defined below) (a “Maintenance Failure”
and collectively with a Filing Failure and an Effectiveness Failure, the “Failures” and each, a “Failure”),
then the Company will make pro rata payments to each Purchaser, as liquidated damages and not as a penalty, in an amount equal
to 1.00% of the aggregate Unit Purchase Price paid by such Purchaser pursuant to the Purchase Agreement for each 30-day period
or pro rata for any portion thereof until such Failure is cured. Such payments shall constitute the Purchasers’ exclusive
monetary remedy for any Failure, but shall not affect the right of the Purchasers to seek injunctive relief. The payments to which
a Purchaser shall be entitled pursuant to this Section 2.2 are referred to herein as “Registration Delay Payments.”
Registration Delay Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Registration
Delay Payments are incurred and (ii) the third (3rd) Business Day after the event or failure giving rise to the Registration Delay
Payments is cured. In the event the Company fails to make Registration Delay Payments in a timely manner, such Registration Delay
Payments shall bear simple interest at the rate of three percent (3.0%) of such unpaid Registration Delay Payment per annum (pro
rated for shorter periods) until paid in full.

 

    5

     

    

 

ARTICLE
III

REGISTRATION PROCEDURES

 

3.1             
Registration Procedures. In connection with the Company’s registration obligations hereunder, the Company shall:

 

(a)              
Prepare and file with the Commission such amendments, including post-effective amendments, to the Registration Statement
as may be necessary to keep the Registration Statement continuously effective (subject to Section 3.1(l)) as to the applicable
Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements,
if necessary, in order to register for resale under the Securities Act all of the Registrable Securities; cause the related Prospectus
to be amended or supplemented by any required Prospectus supplement, and as so supplemented or amended to be filed pursuant to
Rule 424 (or any similar provisions then in force) promulgated under the Securities Act; respond promptly to any comments received
from the Commission with respect to the Registration Statement or any amendment thereto and promptly provide the Holders true and
complete copies of all correspondence from and to the Commission relating to such Registration Statement; and comply in all material
respects with the provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable Securities
covered by the Registration Statement during the applicable period in accordance with the intended methods of disposition by the
Holders thereof set forth in the Registration Statement as so amended or in such Prospectus as so supplemented.

 

(b)              
At the time the Commission declares the Registration Statement effective, each Holder shall be named as a selling stockholder
in the Registration Statement and the related Prospectus in such a manner as to permit such Holder to deliver such Prospectus to
purchasers of Registrable Securities included in the Registration Statement in accordance with applicable law, subject to the terms
and conditions hereof.

 

    6

     

    

 

(c)              
Promptly notify the Holders of Registrable Securities (i)(A) when a Registration Statement, a Prospectus or any Prospectus
supplement or pre- or post-effective amendment to the Registration Statement is filed; (B) when the Commission notifies the Company
whether there will be a “review” of such Registration Statement and whenever the Commission comments in writing on
such Registration Statement, and if requested by such Holders, furnish to them a copy of such comments and the Company’s
responses thereto and (C) with respect to the Registration Statement or any post- effective amendment filed by the Company, when
the same has become effective; (ii) of any request by the Commission or any other Federal or state governmental authority for amendments
or supplements to the Registration Statement or Prospectus or for additional information of the Company; (iii) of the issuance
by the Commission of any stop order suspending the effectiveness of the Registration Statement covering any or all of the Registrable
Securities or the initiation of any Proceedings for that purpose; (iv) of the receipt by the Company of any notification with respect
to the suspension of the qualification or exemption from qualification of any of the Registrable Securities of the Company for
sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; and (v) of the occurrence of any
event that makes any statement made in the Registration Statement or Prospectus or any document incorporated or deemed to be incorporated
therein by reference untrue in any material respect or that requires any revisions to such Registration Statement, Prospectus or
other documents so that, in the case of such Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading.

 

(d)              
Use reasonable best efforts to avoid the issuance of, and, if issued, to obtain the withdrawal of, (i) any order suspending
the effectiveness of the Registration Statement or (ii) any suspension of the qualification (or exemption from qualification) of
any of the Registrable Securities for sale in any U.S. jurisdiction.

 

(e)              
If requested by the Required Holders (as defined in Section 7.3 hereof), (i) promptly incorporate in a Prospectus supplement
or post-effective amendment to the Registration Statement such information as such Holders reasonably request to be included therein
unless the inclusion of such information would reasonably be expected to expose the Company to liability under federal and state
securities laws and regulations and (ii) make all required filings of such Prospectus supplement or such post-effective amendment
as soon as practicable after the Company has received notification of the matters to be incorporated in such Prospectus supplement
or post-effective amendment.

 

(f)               
Furnish to each Holder, without charge and upon request, at least one conformed copy of each Registration Statement and
each amendment thereto, including financial statements and schedules, and, to the extent requested by such Person, all documents
incorporated or deemed to be incorporated therein by reference, and all exhibits (including those previously furnished or incorporated
by reference) promptly after the filing of such documents with the Commission, provided, that the Company shall have no obligation
to provide any document pursuant to this clause that is available on the Commission’s EDGAR system.

 

    7

     

    

 

(g)              
Promptly deliver to each Holder, without charge, as many copies of the Prospectus or Prospectuses (including each form of
prospectus) and each amendment or supplement thereto as such Persons may reasonably request; and the Company hereby consents to
the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering
and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto to the extent permitted
by federal and state securities laws and regulations.

 

(h)              
Cooperate with the Holders to facilitate the timely preparation and delivery of certificates representing Registrable Securities
of the Company to be sold pursuant to a Registration Statement.

 

(i)                
Upon the occurrence of any event contemplated by Section 3.1(c)(v), as promptly as practicable prepare a supplement or amendment,
including a post-effective amendment, to the Registration Statement or a supplement to the related Prospectus or any document incorporated
or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither
the Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they
were made, not misleading.

 

(j)                
Use reasonable best efforts to cause all Registrable Securities relating to the Registration Statement to be listed on the
TSXV and OTCQB (as such terms are defined in the Purchase Agreement) or any subsequent securities exchange, quotation system or
market, if any, on which similar securities issued by the Company are then listed or traded.

 

(k)              
The Company may require each selling Holder to furnish to the Company information regarding such Holder and the distribution
of such Registrable Securities as is required by law to be disclosed in the Registration Statement, and the Company may exclude
from such registration the Registrable Securities of any such Holder who fails to furnish such information within fifteen (15)
days after receiving such request.

 

(l)                
For not more than thirty (30) consecutive calendar days or for a total of not more than sixty (60) days in any twelve (12)
month period, the Company may suspend the use of any Prospectus included in any Registration Statement contemplated by this Section
3.1(l) in the event that the Company determines in good faith that such suspension is necessary to (A) delay the disclosure of
material non-public information concerning the Company, the disclosure of which at the time is not, in the good faith opinion of
the Company, in the best interests of the Company or (B) amend or supplement the affected Registration Statement or the related
Prospectus so that such Registration Statement or Prospectus shall not include an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein, in the case of the Prospectus
in light of the circumstances under which they were made, not misleading (an “Allowed Delay”); provided, that
the Company shall promptly (a) notify each Holder in writing of the commencement of an Allowed Delay, but shall not (without the
prior written consent of an Holder) disclose to such Holder any material non-public information giving rise to an Allowed Delay,
(b) advise the Holder in writing to cease all sales under the Registration Statement until the end of the Allowed Delay and (c)
use commercially reasonable efforts to terminate an Allowed Delay as promptly as practicable.

 

    8

     

    

 

(m)            
The Company shall use reasonable best efforts to register or qualify, or cooperate with the Holders of the Registrable Securities
included in the Registration Statement in connection with the registration or qualification of, the resale of the Registrable Securities
under applicable securities or “blue sky” laws of such states of the United States as any such Holder requests in writing
and to do any and all other acts or things necessary or advisable to enable the offer and sale in such jurisdictions of the Registrable
Securities covered by the Registration Statement; provided, however, that the Company shall not be required to (i)
qualify generally to do business in any jurisdiction where it is not then so qualified or (ii) take any action that would subject
it to general service of process or to taxation in any jurisdiction to which it is not then so subject.

 

(n)              
The Company will comply with all rules and regulations of the Commission to the extent and so long as they are applicable
to the Registration and will make generally available to its security holders (or otherwise provide in accordance with Section
11(a) of the Securities Act) an earnings statement (which need not be audited) satisfying the provisions of Section 11(a) of the
Securities Act and Rule 158 thereunder, no later than forty-five (45) days after the end of a 12-month period (or ninety (90) days,
if such period is a fiscal year) beginning with the Company’s first fiscal quarter commencing after the effective date of
the Registration Statement.

 

3.2             
Holder Obligations.

 

(a)              
At least five (5) Business Days prior to the first anticipated filing date of a Registration Statement, the Company shall
notify each Holder in writing of the information the Company requires from each such Holder if such Holder elects to have any of
such Holder’s Registrable Securities included in such Registration Statement. It shall be a condition precedent to the obligations
of the Company to complete the registration pursuant to this Agreement with respect to the Registrable Securities of a particular
Holder that (i) such Holder furnish to the Company such information regarding itself, the Registrable Securities held by it and
the intended method of disposition of the Registrable Securities held by it as shall be reasonably required to effect the effectiveness
of the registration of such Registrable Securities, and (ii) the Holder execute such documents in connection with such registration
as the Company may reasonably request.

 

(b)              
Each Holder covenants and agrees by its acquisition of such Registrable Securities that (i) it will not sell any Registrable
Securities under the Registration Statement until it has received copies of the Prospectus as then amended or supplemented as contemplated
in Section 3.1(g) and notice from the Company that such Registration Statement and any post-effective amendments thereto have become
effective as contemplated by Section 3.1(c)(i)–(ii) and its officers, directors or Affiliates, if any, will comply with the
prospectus delivery requirements of the Securities Act as applicable to them in connection with sales of Registrable Securities
pursuant to the Registration Statement.

 

    9

     

    

 

(c)              
Upon receipt of a notice from the Company of the occurrence of any event of the kind described in Section 3.1(c)(ii)–(v)
or Section 3.1(l), such Holder will forthwith discontinue disposition of such Registrable Securities under the Registration Statement
until such Holder’s receipt of the copies of the supplemented Prospectus and/or amended Registration Statement contemplated
by Section 3.1(i), or until it is advised in writing by the Company that the use of the applicable Prospectus may be resumed, and,
in either case, has received copies of any additional or supplemental filings that are incorporated or deemed to be incorporated
by reference in such Prospectus or Registration Statement.

 

ARTICLE
IV

REGISTRATION EXPENSES

 

4.1             
Registration Expenses. All reasonable fees and expenses incident to the performance of or compliance with this Agreement
by the Company (excluding underwriters’ discounts and commissions and all fees and expenses of legal counsel, accountants
and other advisors for any Purchaser except as specifically provided below), except as and to the extent specified in this Section
4.1, shall be borne by the Company whether or not a Registration Statement is filed by the Company or becomes effective and whether
or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing
sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses
(A) with respect to filings required to be made with the TSXV, OTCQB and each other securities exchange or market on which Registrable
Securities are required hereunder to be listed, (B) with respect to filings required to be made by the Company with the Financial
Industry Regulatory Authority and (C) in compliance with state securities or “blue sky” laws by the Company or with
respect to Registrable Securities, (ii) messenger, telephone and delivery expenses, (iii) fees and disbursements of counsel for
the Company, (iv) Securities Act liability insurance, if the Company so desires such insurance, and (v) fees and expenses of all
other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement, including,
without limitation, the Company’s independent public accountants. In addition, the Company shall be responsible for all of
its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including,
without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense
of any annual audit, the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities
exchange as required hereunder. In no event shall the Company be responsible for any underwriting, broker or similar fees or commissions
of any Purchaser or, except to the extent provided for above or in the Transaction Documents, any legal fees or other costs of
the Purchasers.

 

    10

     

    

 

ARTICLE
V

INDEMNIFICATION

 

5.1             
Indemnification by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and
hold harmless each Holder, its permitted assignees, officers, directors, agents, brokers (including brokers who offer and sell
Registrable Securities as principal as a result of a pledge or any failure to perform under a margin call of Company Common Stock),
underwriters, investment advisors and employees, each Person who controls any such Holder or permitted assignee (within the meaning
of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, agents and employees of each
such controlling Person, and the respective successors, assigns, estate and personal representatives of each of the foregoing,
to the fullest extent permitted by applicable law, from and against any and all claims, losses, damages, liabilities, penalties,
judgments, costs (including, without limitation, costs of investigation) and expenses (including, without limitation, reasonable
attorneys’ fees and expenses) (collectively, “Losses”), arising out of or relating to any untrue or alleged
untrue statement of a material fact contained in the Registration Statement, any Prospectus, as supplemented or amended, if applicable,
or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or form of prospectus or supplement thereto, in the light of the
circumstances under which they were made) not misleading, except (i) to the extent, but only to the extent, that such untrue statements
or omissions or alleged untrue statements or omissions are based upon information regarding such Holder furnished in writing to
the Company by such Holder expressly for use in such Registration Statement, such Prospectus or in any amendment or supplement
thereto or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of
Registrable Securities and was furnished in writing by such Holder expressly for use therein (it being understood that each Holder
has approved Annex A hereto for this purpose); or (ii) in the case of an occurrence of an event of the type specified in
Section 3.1(c)(ii)-(v), the use by a Holder of an outdated or defective Prospectus, but only if and to the extent that the Company
has advised the Holder that it no longer meets the requirements for the use of Rule 172 and as a result thereof the Holder is required
to deliver a current Prospectus to any transferee of Registrable Securities and has provided a copy of a current Prospectus to
the Holder prior to the sale or transfer of Registrable Securities giving rise to such Losses. The Company shall notify such Holder
promptly of the institution, threat or assertion of any Proceeding of which the Company is aware in connection with the transactions
contemplated by this Agreement. Such indemnity shall remain in full force and effect regardless of any investigation made by or
on behalf of an Indemnified Party (as defined in Section 5.3(a) hereof) and shall survive the transfer of the Registrable Securities
by the Holder.

 

5.2             
Indemnification by Holders. Each Holder and its permitted assignees shall, severally and not jointly, indemnify and
hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such
controlling Persons, and the respective successors, assigns, estate and personal representatives of each of the foregoing, to the
fullest extent permitted by applicable law, from and against all Losses, as incurred, arising out of or relating to any untrue
or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus, as supplemented or amended,
if applicable, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein
or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in the light of the circumstances
under which they were made) not misleading, to the extent, but only to the extent, that such untrue statement or omission or alleged
untrue statement or omission is contained in or omitted from any information regarding such Holder furnished in writing to the
Company by such Holder expressly for use in therein, and that such information was reasonably relied upon by the Company for use
therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of
Registrable Securities and was furnished in writing by such Holder expressly for use therein (it being understood that each Holder
has approved Annex A hereto for this purpose). In no event shall the liability of a Holder be greater in amount than the
dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5.2
and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received
by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification
obligation.

 

    11

     

    

 

5.3             
Conduct of Indemnification Proceedings.

 

(a)              
If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder (an “Indemnified
Party”), such Indemnified Party promptly shall notify the Person from whom indemnity is sought (the “Indemnifying
Party”) in writing, and the Indemnifying Party shall assume the defense thereof, including the employment of counsel
reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense thereof;
provided, that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its
obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a
court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have proximately
and materially adversely prejudiced the Indemnifying Party.

 

(b)              
An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense
thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the
Indemnifying Party has agreed in writing to pay such fees and expenses; or (2) the Indemnifying Party shall have failed promptly
to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding;
or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying
Party, and such Indemnified Party shall have been advised by counsel (which shall be reasonably acceptable to the Indemnifying
Party) that a conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying
Party (in which case, the Indemnifying Party shall be responsible for reasonable fees and expenses of no more than one counsel
(together with appropriate local counsel) for the Indemnified Parties). The Indemnifying Party shall not be liable for any settlement
of any such Proceeding effected without its written consent, which consent shall not be unreasonably withheld or delayed. No Indemnifying
Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect
of which any Indemnified Party is or could have been a party, unless such settlement (i) includes an unconditional release of such
Indemnified Party from all liability on claims that are the subject matter of such Proceeding and (ii) does not include a statement
as to or an admission of fault, culpability or a failure to act by or on behalf of any Indemnified Party.

 

    12

     

    

 

(c)              
All reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred
in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section 5.3) shall
be paid to the Indemnified Party, as incurred, within twenty (20) Business Days of written notice thereof to the Indemnifying Party
(regardless of whether it is ultimately determined that an Indemnified Party is not entitled to indemnification hereunder; provided,
that the Indemnifying Party may require such Indemnified Party to undertake to reimburse all such fees and expenses to the extent
it is finally judicially determined that such Indemnified Party is not entitled to indemnification hereunder).

 

5.4             
Contribution.

 

(a)              
If a claim for indemnification under Section 5.1 or 5.2 is unavailable to an Indemnified Party because of a failure or refusal
of a governmental authority to enforce such indemnification in accordance with its terms (by reason of public policy or otherwise),
then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by
such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying
Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any
other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined
by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material
fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such
Indemnifying, Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity
to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall
be deemed to include, subject to the limitations set forth in Section 5.3, any reasonable attorneys’ or other reasonable
fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified
for such fees or expenses if the indemnification provided for in this Section 5.4 was available to such party in accordance with
its terms.

 

(b)              
The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5.4 were determined
by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred
to in the immediately preceding paragraph. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.
In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount
of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5.4 and the amount
of any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission
or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.

 

(c)              
The indemnity and contribution agreements contained in this Article V are in addition to any liability that the Indemnifying
Parties may have to the Indemnified Parties.

 

    13

     

    

 

ARTICLE
VI

RULE 144

 

6.1             
Rule 144. With a view to making available to the Holders the benefits of Rule 144 (or its successor rule) and any
other rule or regulation of the Commission that may at any time permit the Holders to sell shares of Common Stock to the public
without registration, the Company covenants and agrees to: (i) make and keep public information available, as those terms are understood
and defined in Rule 144, until the earlier of (A) six months after such date as all of the Registrable Securities may be sold without
restriction by the holders thereof pursuant to Rule 144 or any other rule of similar effect or (B) such date as all of the Registrable
Securities shall have been resold pursuant to a Registration Statement, Rule 144 or otherwise in a transaction in which the transferee
receives freely tradable shares; (ii) file with the Commission in a timely manner all reports and other documents required of the
Company under the Exchange Act; and (iii) furnish to each Holder upon request, as long as such Holder owns any Registrable Securities,
(A) a written statement by the Company that it has complied with the reporting requirements of the 1934 Act, (B) a copy of the
Company’s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q, and (C) such other information as may
be reasonably requested in order to avail such Holder of any rule or regulation of the Commission that permits the selling of any
such Registrable Securities without registration. In the event that the Company fails to comply with the requirements of this Section
6.1 after the 180th day after the Closing Date, the Company will make pro rata payments to each Holder, as liquidated damages and
not as a penalty, in an amount equal to 1.00% of the aggregate Unit Purchase Amount paid by such Holder pursuant to the Purchase
Agreement for each 30-day period or pro rata for any portion thereof until such failure is cured or until such time as there are
no more Registrable Securities; provided, however, that only Holders that have not sold or otherwise disposed of
all of their Registrable Securities prior to such failure shall be entitled to receive liquidated damages pursuant to this Section
6.1. Such payments shall constitute the Holder’s exclusive monetary remedy for such events, but shall not affect the right
of the Holders to seek injunctive relief. Such payments shall be made to each Holder in cash no later than three (3) Business Days
after the end of each 30-day period.

 

ARTICLE
VII

MISCELLANEOUS

 

7.1             
Effectiveness. The Company’s obligations hereunder shall be conditioned upon the occurrence of the Closing
under the Purchase Agreement, and this Agreement shall not be effective until such Closing. If the Purchase Agreement shall be
terminated prior to the Closing, then this Agreement shall be void and of no further force or effect (and no party hereto shall
have any rights or obligations with respect to this Agreement).

 

7.2             
Remedies. In the event of a breach by the Company or by a Holder of any of their obligations under this Agreement,
each non-breaching Holder and Company, as the case may be, in addition to being entitled to exercise all rights granted by law
and under this Agreement, including recovery of damages, will be entitled to specific performance of its rights under this Agreement.
The Company and each Holder agree that monetary damages would not provide adequate compensation for any losses incurred by reason
of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific
performance in respect of such breach, it shall waive the defense that a remedy at law would be adequate.

 

    14

     

    

 

7.3             
Entire Agreement; Amendment. This Agreement and the other Transaction Documents contain the entire understanding
and agreement of the parties with respect to the matters covered hereby and, except as specifically set forth herein or therein,
neither the Company nor any Holder make any representation, warranty, covenant or undertaking with respect to such matters, and
they supersede all prior understandings and agreements with respect to said subject matter, all of which are merged herein. This
Agreement and any term hereof may be amended, terminated or waived only with the written consent of the Company and (x) any Holder
who, together with its Affiliates, beneficially owns at least 9.99% of the Registrable Securities and (y) the Holders of at least
a majority of all outstanding Registrable Securities then held by all Holders (the “Required Holders”). Any
amendment or waiver effected in accordance with this Section 7.3 shall be binding upon each Holder (and their permitted assigns).

 

7.4             
No Inconsistent Agreements. The Company will not on or after the date of this Agreement enter into any agreement
with respect to its securities that is inconsistent with the rights granted to the Holders in this Agreement or otherwise conflicts
with the provisions hereof. The rights granted to the Holders hereunder do not in any way conflict with and are not inconsistent
with the rights granted to the holders of the Company’s securities under any agreement in effect on the date hereof.

 

7.5             
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder
shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if
such notice or communication is delivered via facsimile or email at the facsimile number or email address specified in this
Section prior to 4:00 p.m. (Eastern time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice
or communication is delivered via facsimile or email at the facsimile number or e-mail address specified
in this Section on a day that is not a Trading Day or later than 4:00 p.m. (Eastern time) on any Trading Day, (c) the Trading Day
following the date of deposit with a nationally recognized overnight courier service, or (d) upon actual receipt by the party to
whom such notice is required to be given. The addresses, facsimile numbers and email addresses for such notices and communications
are those set forth below, or such other address or facsimile number as may be designated in writing hereafter, in the same manner,
by any such Person:

 

	If to the Company:	 	
        Assure Holdings Corp.

        4600 South Ulster Street, Suite 1225

        Denver, CO 80237

Attention: John Allen Farlinger, Chairman & CEO

Email: john.farlinger@assureiom.com

Fax No.:

	 	 	 
	with copies (which copies shall not constitute notice to the Company) to:	 	
        Dorsey & Whitney LLP

        1400 Wewatta Street, Suite 400

        Denver, CO 80202

        Attention: Kenneth G. Sam, Esq.

        Email: sam.kenneth@dorsey.com

        Fax No.: (416) 367-7371

	 	 	 
	If to the Purchasers:	 	To their respective addresses as set forth on Schedule 1 attached hereto.

 

    15

     

    

 

7.6             
Waivers. No waiver by either party of any default with respect to any provision, condition or requirement of this
Agreement shall be deemed to be a continuing waiver in the future or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such
right accruing to it thereafter.

 

7.7             
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns and shall inure to the benefit of each Holder and its successors and assigns. The Company may not assign
this Agreement or any of its rights or obligations hereunder without the prior written consent of the Holders of at least a majority
of all Registrable Securities then outstanding.

 

7.8             
Assignment of Registration Rights. The rights of each Holder hereunder, including the right to have the Company register
for resale Registrable Securities in accordance with the terms of this Agreement, shall be assignable by each Holder of all or
a portion of the Registrable Securities if: (i) the Holder agrees in writing with the transferee or assignee to assign such rights,
and a copy of such agreement is furnished to the Company within a reasonable time after such assignment, (ii) the Company is, within
a reasonable time after such transfer or assignment, furnished with written notice of (a) the name and address of such transferee
or assignee, and (b) the Registrable Securities with respect to which such registration rights are being transferred or assigned
to such transferee or assignee, (iii) following such transfer or assignment the further disposition of such securities by the transferee
or assignees is restricted under the Securities Act and applicable state securities laws to the extent required, (iv) at or before
the time the Company receives the written notice contemplated by clause (ii) of this Section 7.8, the transferee or assignee agrees
in writing with the Company to be bound by all of the provisions of this Agreement, and (v) such transfer shall have been made
in accordance with the requirements of applicable law. The rights to assignment shall apply to the Holders (and to subsequent)
successors and assigns.

 

7.9             
Counterparts. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic
mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other
transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective
for all purposes.

 

7.10           
Termination. This Agreement shall terminate at the end of the Effectiveness Period, except that Articles IV and V
and this Article VII shall remain in effect in accordance with their terms.

 

    16

     

    

 

7.11         
Governing Law; Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the internal
laws of the State of New York without regard to the conflict of law principles thereof. Each of the parties hereto irrevocably
submits to the exclusive jurisdiction of the state and federal courts located in the State of New York for the purpose of any suit,
action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated hereby. Service of
process in connection with any such suit, action or proceeding may be served on each party hereto anywhere in the world by the
same methods as are specified for the giving of notices under this Agreement. Each of the parties hereto irrevocably consents to
the jurisdiction of any such court in any such suit, action or proceeding and to the laying of venue in such court. Each party
hereto irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts and
irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient
forum. If any party hereto shall commence an action or proceeding to enforce any provisions of the Transaction Documents, then,
the prevailing party in such action or proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys’
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.

 

7.12         
Cumulative Remedies. The remedies provided herein are cumulative and not exclusive of any remedies provided by law.

 

7.13         
Severability. If any provision hereof should be held invalid, illegal or unenforceable in any respect, then, to the
fullest extent permitted by law, (a) all other provisions hereof shall remain in full force and effect and shall be liberally construed
in order to carry out the intentions of the parties as nearly as may be possible and (b) the parties shall use their best efforts
to replace the invalid, illegal or unenforceable provision(s) with valid, legal and enforceable provision(s) which, insofar as
practical, implement the purposes of such provision(s) in this Agreement.

 

7.14         
Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall
not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party.

 

[Signature pages to follow]

 

    17

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Registration Rights Agreement to be duly executed by their respective
authorized officers as of the date first above written.

 

	 	THE COMPANY:
	 	 
	 	ASSURE HOLDINGS CORP.
	 	 
	 	 
	 	By:	 
	 	 	Name:	John Allen Farlinger
	 	 	Title:	Chairman and Chief Executive Officer

 

     

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Registration Rights Agreement to be duly executed by their respective
authorized officers as of the date first above written.

 

	 	PURCHASERS:  
	 	 
	 	[PURCHASER]  
	 	 
	 	By:	                
	 	Name:	 
	 	Title:	 

 

     

     

    

 

ANNEX A

PLAN OF DISTRIBUTION

 

The selling stockholders,
which as used herein includes donees, pledgees, transferees or other successors-in-interest selling shares of common stock previously
issued and the shares of common stock issuable upon exercise of the warrants, or interests in shares of common stock received after
the date of this prospectus from a selling stockholder as a gift, pledge, partnership distribution or other transfer, may, from
time to time, sell, transfer or otherwise dispose of any or all of their shares of common stock or interests in shares of common
stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions. The selling
stockholders may sell their shares of our common stock pursuant to this prospectus at fixed prices, at prevailing market prices
at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at
negotiated prices.

 

The selling stockholders
may use any one or more of the following methods when disposing of shares or interests therein:

 

		·	ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

 

		·	block trades in which the broker-dealer will attempt to sell the shares as agent, but may position
and resell a portion of the block as principal to facilitate the transaction;

 

		·	purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

 

		·	an exchange distribution in accordance with the rules of the applicable exchange;

 

		·	privately negotiated transactions;

 

		·	short sales;

 

		·	through the writing or settlement of options or other hedging transactions, whether through an
options exchange or otherwise;

 

		·	broker-dealers may agree with the selling stockholders to sell a specified number of such shares
at a stipulated price per share;

 

		·	a combination of any such methods of sale; and

 

		·	any other method permitted pursuant to applicable law.

 

The selling stockholders
may, from time to time, pledge or grant a security interest in some or all of the shares of common stock or warrants owned by them
and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares
of common stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other
applicable provision of the Securities Act amending the list of selling stockholders to include the pledgee, transferee or other
successors in interest as selling stockholders under this prospectus. The selling stockholders also may transfer the shares of
common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling
beneficial owners for purposes of this prospectus.

 

     

     

    

 

In connection with
the sale of our common stock or interests therein, the selling stockholders may enter into hedging transactions with broker- dealers
or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions
they assume. The selling stockholders may also sell shares of our common stock short and deliver these securities to close out
their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling
stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation
of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares
offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus
(as supplemented or amended to reflect such transaction).

 

The aggregate proceeds
to the selling stockholders from the sale of the common stock offered by them will be the purchase price of the common stock less
discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with their agents
from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents.
We will not receive any of the proceeds from this offering.

 

The selling stockholders
and any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests therein may be “underwriters”
within the meaning of Section 2(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn on any resale
of the shares may be underwriting discounts and commissions under the Securities Act. Selling stockholders who are “underwriters”
within the meaning of Section 2(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities
Act.

 

To the extent required,
the shares of our common stock to be sold, the names of the selling stockholders, the respective purchase prices and public offering
prices, the names of any agents, dealer or underwriter, any applicable commissions or discounts with respect to a particular offer
will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement
that includes this prospectus.

 

In order to comply
with the securities laws of some states, if applicable, the common stock may be sold in these jurisdictions only through registered
or licensed brokers or dealers. In addition, in some states the common stock may not be sold unless it has been registered or qualified
for sale or an exemption from registration or qualification requirements is available and is complied with.

 

We have advised the
selling stockholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the
market and to the activities of the selling stockholders and their affiliates. In addition, we will make copies of this prospectus
(as it may be supplemented or amended from time to time) available to the selling stockholders for the purpose of satisfying the
prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates
in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities
Act.

 

     

     

    

 

We have agreed to indemnify
the selling stockholders against liabilities, including liabilities under the Securities Act and state securities laws, relating
to the registration of the shares offered by this prospectus.

 

We have agreed with
the selling stockholders to keep the registration statement of which this prospectus constitutes a part effective until such time
as the shares offered by the selling stockholders have been effectively registered under the Securities Act and disposed of in
accordance with such registration statement, the shares offered by the selling stockholders have been disposed of pursuant to Rule
144 under the Securities Act or the shares offered by the selling stockholders may be resold pursuant to Rule 144 without restriction
or limitation (including without the requirement to be in compliance with Rule 144(c)(1)) or another similar exemption under the
Securities Act.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]